Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Blistex Kank-Eze

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 20 g/100 mL
Other brand names
Dosage form
Gel
Route
Buccal
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2012
Label revision date
June 6, 2016
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 20 g/100 mL
Other brand names
Dosage form
Gel
Route
Buccal
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2012
Label revision date
June 6, 2016
Manufacturer
Blistex Inc.
NDC root
10157-9411
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be curious about a medication that comes in a 5 mL bottle carton. While specific details about its name and uses are not provided, it is important to know that this medication is associated with an observation media that includes a description of its packaging. This suggests that the medication is likely intended for a specific purpose, although the exact use and mechanism of action are not detailed in the information available.

If you have any questions about this medication or its intended use, it's always a good idea to consult with a healthcare professional who can provide you with more personalized information and guidance.

Uses

It seems that there are no specific indications or uses provided for this medication. This means that the information about what this drug is intended to treat or how it can be used is not available. If you have any questions or need further information about this medication, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

To use this medication, you will apply it directly to the affected area inside your mouth, specifically in the buccal cavity (the space between your gums and the inside of your cheeks). The active ingredient in this medication is benzocaine, which is present at a concentration of 20 grams in every 100 milliliters of the solution.

Make sure to follow the directions provided for how much to apply and how often. It's important to use the medication exactly as directed to ensure it works effectively and safely. If you have any questions about the application or dosage, don't hesitate to ask your healthcare provider for clarification.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance) or any explicit instructions on what to avoid while using this medication.

It's always important to consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for you.

Side Effects

You may experience some side effects while using this medication. Common reactions include skin irritation, rash, nausea, vomiting, dizziness, and headaches. Some people may also have difficulty breathing or experience a rapid heartbeat (tachycardia).

It's important to be aware that allergic reactions can occur, including severe cases like anaphylaxis (a life-threatening allergic reaction). If you have a history of allergic reactions to local anesthetics, you should use this medication with caution. Always consult your healthcare provider if you have concerns about these side effects.

Warnings and Precautions

It's important to be aware that there are currently no specific warnings, precautions, or laboratory tests associated with this medication. This means that, as of now, there are no known risks or necessary monitoring that you need to be concerned about while using it.

However, if you experience any unusual symptoms or reactions while taking this medication, it's always a good idea to stop using it and consult your doctor for further guidance. Your health and safety are paramount, so don't hesitate to reach out if you have any questions or concerns.

Overdose

If you take too much benzocaine, it can lead to a serious condition called methemoglobinemia, which affects your blood's ability to carry oxygen. This can cause symptoms such as a bluish discoloration of the skin (known as cyanosis), headache, fatigue, shortness of breath, and a faster heart rate.

If you suspect an overdose, it’s crucial to seek immediate medical attention. Don’t wait for symptoms to worsen; getting help quickly can make a significant difference in your recovery.

Pregnancy Use

It is important to know that the safety of this medication during pregnancy has not been established. Because of potential risks to the developing fetus, it is not recommended for use while you are pregnant. If you are planning to become pregnant or are currently pregnant, be sure to discuss any medications you are taking with your healthcare provider to ensure the best care for you and your baby.

Lactation Use

When it comes to breastfeeding, it's important to be aware that there are no specific guidelines or statements regarding nursing mothers or lactation (the process of producing milk). This means that if you are breastfeeding, you may not find detailed information about how certain medications or treatments could affect you or your baby.

If you have concerns about breastfeeding while taking any medication, it's always best to consult with your healthcare provider for personalized advice and to ensure the safety of both you and your infant.

Pediatric Use

It's important to know that the use of Blistex Kank-Eze (benzocaine gel) in children has not been established. This means that there hasn't been enough research to confirm whether it is safe and effective for kids. As a parent or caregiver, you should be cautious and consult with a healthcare professional before using this product on children, as the safety and effectiveness in pediatric patients have not been determined. Always prioritize your child's health and well-being by seeking expert advice.

Geriatric Use

While there is no specific information about the use of Blistex Kank-Eze (benzocaine gel) in older adults, it's important to approach its use with caution. Since the drug insert does not mention any dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can provide personalized advice based on your health status and any other medications you may be taking. Always prioritize safety and ensure that any treatment is appropriate for your individual needs.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert for Blistex Kank-Eze (benzocaine gel) does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this product may affect you if you have liver impairment.

Before using this product, it’s a good idea to consult with your healthcare provider to ensure it’s safe for you, especially since individual health conditions can vary widely. Your doctor can help determine the best approach for your care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no known drug interactions or laboratory test interactions associated with them. This ensures that your treatment plan is safe and effective for your individual health needs.

Always keep your healthcare team informed about all the medications and supplements you use, as well as any lab tests you may undergo. This way, they can provide the best care tailored to you.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature, away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is the route of administration for Blistex Kank-Eze?

The route of administration for Blistex Kank-Eze is buccal.

How should I use Blistex Kank-Eze?

Apply a small amount of Blistex Kank-Eze benzocaine gel directly to the affected area in the buccal cavity as needed.

What is the active ingredient in Blistex Kank-Eze?

The active ingredient in Blistex Kank-Eze is benzocaine, with a concentration of 20 g in 100 mL.

Are there any contraindications for using Blistex Kank-Eze?

There are no specific contraindications listed, but it is not recommended during pregnancy due to potential risks to the fetus.

What are some possible adverse reactions to Blistex Kank-Eze?

Possible adverse reactions include allergic reactions, skin irritation, nausea, dizziness, and difficulty breathing.

Is Blistex Kank-Eze safe for pediatric use?

Pediatric use has not been established for Blistex Kank-Eze, and safety and effectiveness in children have not been determined.

What should I do if I experience an allergic reaction?

If you experience hypersensitivity reactions, including anaphylaxis, seek emergency medical help immediately.

How should I store Blistex Kank-Eze?

Store Blistex Kank-Eze at room temperature, protect it from light, keep the container tightly closed, and discard it after opening.

Packaging Info

Below are the non-prescription pack sizes of Blistex Kank-Eze (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blistex Kank-Eze.
Details

Drug Information (PDF)

This file contains official product information for Blistex Kank-Eze, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the overall clinical context when prescribing this medication.

Dosage and Administration

The active ingredient, Benzocaine, is to be administered buccally at a concentration of 20 g in 100 mL. Healthcare professionals should apply the medication as directed to the affected area within the buccal cavity. It is essential to ensure that the application is performed with care to maximize efficacy and minimize discomfort.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions advising against its use in any particular conditions or situations.

Warnings and Precautions

There are currently no specific warnings or precautions associated with the use of this medication. Healthcare professionals are advised to remain vigilant and monitor patients for any unexpected reactions or side effects during treatment.

As there are no recommended laboratory tests or specific monitoring parameters outlined, it is essential for healthcare providers to use clinical judgment and consider individual patient circumstances when determining the need for any laboratory evaluations.

In the event of any adverse reactions or concerning symptoms, healthcare professionals should instruct patients to seek immediate medical assistance. Additionally, if a patient experiences significant side effects or has concerns regarding their treatment, they should be advised to discontinue use and consult their healthcare provider for further guidance.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions include hypersensitivity reactions, which can manifest as anaphylaxis. Patients with a history of allergic reactions to local anesthetics should use this medication with caution due to the potential for such reactions.

Common adverse reactions reported include dermatologic, gastrointestinal, neurological, respiratory, and cardiovascular effects. Dermatologic reactions may present as skin irritation or rash. Gastrointestinal disturbances can include nausea and vomiting. Neurological effects may manifest as dizziness or headache. Respiratory symptoms may involve difficulty breathing, while cardiovascular reactions can include tachycardia.

Healthcare providers should monitor patients for these adverse reactions and manage them appropriately.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Blistex Kank-Eze (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blistex Kank-Eze.
Details

Pediatric Use

Pediatric use of Blistex Kank-Eze (benzocaine gel) has not been established. Safety and effectiveness in pediatric patients have not been determined. Therefore, caution is advised when considering the use of this product in children, infants, or adolescents.

Geriatric Use

There is no specific information regarding the use of Blistex Kank-Eze (benzocaine gel) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

Safety during pregnancy has not been established for this medication. Use is not recommended during pregnancy due to potential risks to the fetus. Healthcare professionals should consider alternative treatments for pregnant patients to avoid any adverse fetal outcomes. Women of childbearing potential should be counseled on the potential risks associated with the use of this medication during pregnancy.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Blistex Kank-Eze (benzocaine gel). The prescribing information does not provide any recommendations regarding dosage adjustments, special monitoring, or precautions for individuals with compromised liver function. Therefore, healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment.

Overdosage

Overdosage of benzocaine can lead to methemoglobinemia, a potentially serious condition characterized by a reduced capacity of the blood to transport oxygen. This condition arises when an excessive amount of benzocaine is absorbed into the bloodstream, resulting in altered hemoglobin function.

Symptoms The clinical manifestations of methemoglobinemia may include cyanosis, which presents as a bluish discoloration of the skin, as well as headache, fatigue, shortness of breath, and an increased heart rate. These symptoms can vary in severity depending on the extent of the overdose and the individual's response.

Recommended Actions In the event of a suspected overdose, it is imperative to seek immediate medical attention. Prompt intervention is crucial to mitigate the risks associated with methemoglobinemia and to initiate appropriate management strategies. Healthcare professionals should be prepared to assess the patient's condition and provide necessary treatments, which may include oxygen therapy and the administration of methylene blue in severe cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the medication is intended for oral use only and must not be applied to broken skin or open wounds. It is important to emphasize the necessity of avoiding contact with the eyes; in the event of contact, patients should rinse their eyes thoroughly with water.

Patients should be instructed not to exceed the recommended dosage. If symptoms persist despite following the directions, they should consult a healthcare professional for further evaluation and guidance.

Additionally, healthcare providers should remind patients to keep the medication out of reach of children. In the case of accidental ingestion, patients should seek medical assistance immediately or contact a Poison Control Center for prompt advice.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to protect the contents from light exposure, which can compromise the product's effectiveness. Additionally, it is important to discard the product after opening to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Blistex Kank-Eze, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Blistex Kank-Eze, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.